I thought so, that is why I had my OB under $10, they gapped it down to $9 or so and got me in a little under my OB... Longer term, I don't think this piece of news is very critical. There are not as many lung cancer patients as skin cancer and few other applications they are working on. I would not be surprised if they did that to conserve resources that can be redeployed in more promising areas. After the CC, it came back quite a lot from the initial drop. They just broought QLTI all the way up to $11.25, that is almost a double bucker, so it is taken off here. OB around $9.5 back in...
Zeev
Market Data 
Markets 
AI
